From: A DoE-based development and characterization of Nadifloxacin-loaded transethosomal gel for the treatment of Acne vulgaris
Responses
R2
Adjusted R2
Predicted R2
S.D
% C.V
Y1 (EE)
0.9985
0.9965
0.9793
0.6
0.85
Y2 (VS)
0.9811
0.9568
0.7963
5.78
4.13
Y3 (ZP)
0.9042
0.8607
0.7028
1.90
6.81